A61K 39/0266
Klebsiella
Official title: {Klebsiella}
A61K39/0266 (Klebsiella) appears on 78 US grants and 112 published applications in this corpus.
Search patents in A61K- Granted patents
- 78
- Published applications
- 112
- Assignees
- 52
- Inventors
- 222
- Latest grant
- 11 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 2 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 2 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 1 |
| 2004 | 1 | 0 |
| 2005 | 1 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 1 | 2 |
| 2009 | 0 | 0 |
| 2010 | 1 | 3 |
| 2011 | 2 | 2 |
| 2012 | 1 | 3 |
| 2013 | 2 | 5 |
| 2014 | 2 | 2 |
| 2015 | 3 | 5 |
| 2016 | 2 | 4 |
| 2017 | 2 | 7 |
| 2018 | 4 | 4 |
| 2019 | 3 | 7 |
| 2020 | 3 | 7 |
| 2021 | 6 | 10 |
| 2022 | 3 | 9 |
| 2023 | 8 | 8 |
| 2024 | 8 | 13 |
| 2025 | 8 | 11 |
| 2026 | 4 | 6 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Klebsiella vaccine and methods of use11 Aug 2026US 12,702,704 B2Cornell University
- Proteins and immunizing compositions containing Klebsiella proteins and methods of use28 Jul 2026US 12,691,167 B2Vaxxinova US, Inc.
- Vaccine21 Jul 2026US 12,685,769 B2Glaxosmithkline Biologicals SA
- Glycosylated comp pilin variants, methods of making and uses thereof17 Mar 2026US 12,577,280 B2Vaxnewmo LLC
- Vaccine compositions and methods for the treatment and prevention of urinary tract infections9 Dec 2025US 12,491,237 B2Duke University
- Immunogenic Composition20 Aug 2026US 2026/0240990 A1Glaxosmithkline Biologicals SA
- Vaccine against klebsiella pneumoniae16 Jul 2026US 2026/0199445 A1Idorsia Pharmaceuticals Ltd
- Vaccine against klebsiella pneumoniae28 May 2026US 2026/0144856 A1Idorsia Pharmaceuticals Ltd
- E. coli fimh mutants and uses thereof7 May 2026US 2026/0124286 A1Pfizer Inc.
- Topical nasal pharmaceutical composition for the treatment and prophylaxis of chronic rhinosinusitis (crs)23 Apr 2026US 2026/0108489 A1
Most cited
By later US patents
- Oral vaccine against gram negative bacterial infection46US 5,730,989 ANovavax, Inc. · 1998
- Prevention and treatment of rheumatoid arthritis36US 4,732,757 AStolle Research & Development Corporation · 1988
- Oligosaccharide derived from an antigenic polysaccharide obtained from a pathogenic agent31US 6,045,805 APasteur Merieux Serums et Vaccines · 2000
- Vaginal suppository vaccine for urogenital infections31US 6,099,853 AProtein Express Co., Ltd. · 2000
- Klebsiella capsular polysaccharide vaccine20US 4,755,381 ASwiss Serum and Vaccine Institute Berne · 1988